Mr. François Blondel is a Co-Founder & serves as Vice-Chairman of the Board at OncoDNA. He served as Chief Executive Officer, Managing Director & Chairman at Delphi Genetics. He is a Co-Founder and serves as Chairman at KIOmed Pharma. He served as Board Member at Ovizio Imaging Systems. He serves as Chief Executive Officer & Managing Director at KitoZyme. Prior to joining KitoZyme, he has gained broad experience in the management of innovation-driven companies. He started his career in the chemical and in oil and gas sectors, with assignments both in the United States and in Europe. In 1999, he joined International Brachytherapy (IBt), a startup in the medical device sector focused on cancer treatment. He served as CEO, leading IBt, a Euronext stock listed company, from its R&D stage to a successful and well-diversified international group, the European leader in its sector. Today, he is also serving as a board member of Compagnie du Bois Sauvage (a diversified holding company listed on Euronext), Sopartec (holding of UCL university spinoffs), Nanocyl (world leader in the production of carbon nanotubes), and a number of other companies active in the technology sector.